Mithra Pharmaceuticals SA (MITRA):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Mithra Pharmaceuticals SA (MITRA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8093
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:65
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ベルギー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Mithra Pharmaceuticals SA (Mithra) is a developer and manufacturer of over the counter products and prescription drugs for women’s health and other applications. The company offers products such as estelle, donesta, tibelia, zoreline and myring, among others. Its products are used in the treatment of contraception and fertility, menopause and osteoporosis, gynecological infections and cancers, among others. Mithra offers its products in polymeric forms, sterile injectable products, and hormonal tablets. It also offers research, development and specialist manufacturing services. The company sells its products through a network of distributors in Belgium, France, Germany and Brazil, among others. Mithra is headquartered in Liege, Belgium.

Mithra Pharmaceuticals SA (MITRA) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Mithra Pharmaceuticals SA, Medical Devices Deals, 2012 to YTD 2018 10
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deal Details 13
Asset Purchase 13
Mithra Pharma Acquires Estetrol from Pantarhei Bioscience 13
Mithra Pharma Acquires Women Health Portfolio from Uteron Pharma 14
Partnerships 15
Mithra Pharma Enters into Agreement with Generic Specialty Pharma 15
Licensing Agreements 16
Pei Li Pharma Enters into Licensing Agreement with Mithra Pharma 16
Richter Gedeon Enters into Licensing Agreement with Mithra Pharma 17
Mediner Enters into Licensing Agreement with Mithra Pharma 18
Searchlight Pharma to Enter into Licensing Agreement with Mithra Pharma 19
Libbs Farmaceutica to Enter into Licensing Agreement with Mithra Pharmaceuticals 20
Fuji Pharma Enters into Licensing Agreement with Mithra Pharma for Donesta 21
Mithra Pharma Enters into Licensing Agreement for Tibelia in Canada 22
Equity Offering 23
Mithra Pharma Raises USD90 Million in Private Placement of Shares 23
Mithra Pharma Raises USD29 Million in Private Placement of Shares 25
Mithra Pharma Raises USD81.4 Million in IPO 26
Asset Transactions 27
Ceres Pharma to Acquire Women’s Health Generic Business from Mithra Pharma 27
Mithra Pharmaceuticals SA – Key Competitors 28
Mithra Pharmaceuticals SA – Key Employees 29
Mithra Pharmaceuticals SA – Locations And Subsidiaries 30
Head Office 30
Other Locations & Subsidiaries 30
Recent Developments 31
Financial Announcements 31
Sep 25, 2018: Mithra announces 2018 half year results 31
Mar 02, 2018: Mithra Reports 2017 Annual Results 36
Sep 21, 2017: Mithra Announces 2017 Half Year Results 41
Mar 02, 2017: Mithra Pharmaceuticals: Mithra reports 2016 annual results 42
Corporate Communications 45
Mar 03, 2017: Mithra signs agreement with Fuji Pharma to commercialise Donesta 45
Jan 19, 2017: USPTO issues Notice of Allowance for Mithra’s application for Estetrol patent 46
Jan 12, 2017: Mithra Pharmaceuticals sets up scientific advisory boards for Donesta 47
Jan 06, 2017: Mithra Pharmaceuticals Appoints Christophe Marechal As Chief Financial Officer 48
Government and Public Interest 49
Feb 13, 2017: Mithra Pharmaceuticals: Mithra Granted EUR 1.9 Million In Non-Dilutive Funding 49
Product News 50
01/12/2017: Mithra’s North American Advisory Board For Donesta to Meet In Miami, Florida 50
Product Approvals 51
Jun 09, 2017: Mithra Receives Orphan Drug Designation From EMA For E4 In Neonatal Encephalopathy 51
Clinical Trials 52
May 03, 2018: Mithra Announces Last Subject Visit in Estelle Phase III Study in EU/Russia and Completion of Endometrial Substudy 52
Mar 23, 2018: Mithra Announces Completion Of Estelle Cycles Required In Phase Iii Contraception Studies 53
Feb 08, 2018: Mithra Announces Very Promising Hemostasis Results for Estelle 54
Nov 30, 2017: Mithra Provides Update On Estelle Study 55
Oct 30, 2017: Mithra Completes Recruitment for Estelle Phase III Study in US & Canada 56
Oct 30, 2017: Mithra Completes Recruitment for Estelle Phase III Study in US and Canada 57
Aug 18, 2017: Mithra Announces First Subject Completes Estelle Phase III Study 58
Aug 09, 2017: Mithra Pharmaceuticals: Recruitment Completed in Estelle Population PK Substudy 59
Jul 06, 2017: Mithra Strengthens E4 Patent Position in Australian Market 60
Jun 26, 2017: Estelle Phase IIB Results on Well-Being and Body Weight Published in Leading Peer-Reviewed journal 61
Jun 21, 2017: Mithra Completes Recruitment For Additional Estelle Safety Study 62
May 12, 2017: Mithra to Initiate PK Study for Estelle 63
Feb 07, 2017: Mithra Completes Recruitment For European Phase III Estelle Study 64
Appendix 65
Methodology 65
About GlobalData 65
Contact Us 65
Disclaimer 65

List of Tables
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Mithra Pharmaceuticals SA, Deals By Therapy Area, 2012 to YTD 2018 9
Mithra Pharmaceuticals SA, Medical Devices Deals, 2012 to YTD 2018 10
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Mithra Pharma Acquires Estetrol from Pantarhei Bioscience 13
Mithra Pharma Acquires Women Health Portfolio from Uteron Pharma 14
Mithra Pharma Enters into Agreement with Generic Specialty Pharma 15
Pei Li Pharma Enters into Licensing Agreement with Mithra Pharma 16
Richter Gedeon Enters into Licensing Agreement with Mithra Pharma 17
Mediner Enters into Licensing Agreement with Mithra Pharma 18
Searchlight Pharma to Enter into Licensing Agreement with Mithra Pharma 19
Libbs Farmaceutica to Enter into Licensing Agreement with Mithra Pharmaceuticals 20
Fuji Pharma Enters into Licensing Agreement with Mithra Pharma for Donesta 21
Mithra Pharma Enters into Licensing Agreement for Tibelia in Canada 22
Mithra Pharma Raises USD90 Million in Private Placement of Shares 23
Mithra Pharma Raises USD29 Million in Private Placement of Shares 25
Mithra Pharma Raises USD81.4 Million in IPO 26
Ceres Pharma to Acquire Women's Health Generic Business from Mithra Pharma 27
Mithra Pharmaceuticals SA, Key Competitors 28
Mithra Pharmaceuticals SA, Key Employees 29
Mithra Pharmaceuticals SA, Subsidiaries 30

List of Figures
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Mithra Pharmaceuticals SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Mithra Pharmaceuticals SA, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Mithra Pharmaceuticals SA (MITRA):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Saudi Electricity Co (5110):企業の財務・戦略的SWOT分析
    Saudi Electricity Co (5110) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Fujikoh Company Ltd-エネルギー分野:企業M&A・提携分析
    Summary Fujikoh Company Ltd (Fujikoh Company) is a clean technology company that offers waste recycling services. The company provides biomass and environmental recycling services. It offers construction waste recycling, waste food recycling and termite dismantling and demolition services. Fujikoh C …
  • Polaris Infrastructure Inc (PIF):企業の財務・戦略的SWOT分析
    Summary Polaris Infrastructure Inc (Polaris Infrastructure), formerly Ram Power Corp is a renewable energy company that explores, acquires, operates and develops geothermal energy projects in Latin America. The company owns and operates San Jacinto Tizate Geothermal project, which is located in nort …
  • Korea Electric Power Corp (015760):電力:M&Aディール及び事業提携情報
    Summary Korea Electric Power Corp (KEPCO) is an integrated electric utility. It generates, transmits, and distributes electricity. The company produces electricity using nuclear, thermal, renewable, and other sources. Through power purchase agreements with independent power producers, KEPCO procures …
  • SK Hand Tool LLC:企業の戦略的SWOT分析
    SK Hand Tool LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • The Dow Chemical Co-エネルギー分野:企業M&A・提携分析
    Summary The Dow Chemical Company (Dow), a subsidiary of DowDupont is a diversified chemical company. Its businesses encompass specialty chemicals, advanced materials, agrosciences and plastics. The company manufactures and supplies products used primarily as raw materials in the manufacture of custo …
  • Global Tungsten & Powders Corp.:企業の戦略・SWOT・財務情報
    Global Tungsten & Powders Corp. - Strategy, SWOT and Corporate Finance Report Summary Global Tungsten & Powders Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Medical Australia Ltd:医療機器:M&Aディール及び事業提携情報
    Summary Medical Australia Ltd (Medical Australia), formerly BMDI TUTA Healthcare Pty Ltd is a medical device company that offers sterile and non-sterile medical plastics; wall suction, medical gas and suction pump products. The company's suction pumps include a range of mobile, portable and manual s …
  • Galp Energia SGPS SA (GALP):電力:M&Aディール及び事業提携情報
    Summary Galp Energia SGPS SA (Galp) is an integrated energy company. It explores for, develops and produces crude oil and natural gas, refines crude oil, and markets refined petroleum products. The company also conducts power generation, produces biodiesel and trades gas. It imports, transports and …
  • Fujirebio Europe NV:企業の戦略的SWOT分析
    Fujirebio Europe NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Universal Music Group Inc:企業の戦略的SWOT分析
    Universal Music Group Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Awarepoint Corp:医療機器:M&Aディール及び事業提携情報
    Summary Awarepoint Corp (Awarepoint) is a healthcare technology company that provides real time location system. The company offers technology, software and managed services. It provides location software packages for mobile phones and other electronics. Awarepoint’s software packages provide patien …
  • CompuGroup Medical Deutschland AG (COP):医療機器:M&Aディール及び事業提携情報
    Summary CompuGroup Medical Deutschland AG (CGM) is a provider of medical software products and healthcare services. The company provides products such as communication solutions, software assisted medicine, dentist information systems, ambulatory information systems, drug safety and patient marketin …
  • MOIL Ltd:企業の戦略・SWOT・財務分析
    MOIL Ltd - Strategy, SWOT and Corporate Finance Report Summary MOIL Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Nobilis Health Corp (NHC):企業の財務・戦略的SWOT分析
    Summary Nobilis Health Corp (Nobilis Health), formerly Northstar Healthcare Inc is a healthcare development and management company that offers outpatient surgery and healthcare solutions. The center’s services include surgical services, surgery and critical patient education services. Its surgical s …
  • Purdue Pharma Canada-製薬・医療分野:企業M&A・提携分析
    Summary Purdue Pharma Canada (Purdue Pharma), a subsidiary of Purdue Pharma L.P., is a research-based pharmaceutical company which focuses on development, manufacturing and commercialization of medicines for patients and healthcare professionals. The company portfolio of products includes laxatives, …
  • Pearson Engineering Limited:企業の戦略・SWOT・財務情報
    Pearson Engineering Limited - Strategy, SWOT and Corporate Finance Report Summary Pearson Engineering Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Amedisys, Inc.:企業の戦略・SWOT・財務情報
    Amedisys, Inc. - Strategy, SWOT and Corporate Finance Report Summary Amedisys, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Eurobank Ergasias SA:戦略・SWOT・企業財務分析
    Eurobank Ergasias SA - Strategy, SWOT and Corporate Finance Report Summary Eurobank Ergasias SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • W.O.M. World of Medicine GmbH:企業の戦略的SWOT分析
    W.O.M. World of Medicine GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆